Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,518) with videos related to
Page
of 152
Sort By:
BMJ Open
|
January 21, 2022
Study protocol of the COMPARE-Interaction study: the impact of maternal comorbid depression and anxiety disorders in the peripartum period on child development
Anna-Lena Zietlow, Christian Franz Josef Woll, Nora Nonnenmacher, et al.
Virchows Archiv : an International Journal of Pathology
|
August 9, 2019
Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients
C Kuempers, L I S van der Linde, M Reischl, et al.
Journal of Thoracic Disease
|
June 11, 2019
Circulating free tumor-derived DNA to detect <i>EGFR</i> mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study
Marc G Denis, Marie-Pierre Lafourcade, Gwenaëlle Le Garff, et al.
Experimental Neurology
|
July 20, 2012
Essential tremor and tremor in Parkinson's disease are associated with distinct 'tremor clusters' in the ventral thalamus
David J Pedrosa, Christiane Reck, Esther Florin, et al.
Journal of Wildlife Diseases
|
January 31, 2024
Molecular Survey of Haemosporidian Parasites in Procellariiformes Sampled in Southern Brazil, 2013-22
Annelise Zabel Sgarioni, Patricia Serafini, Alice Pereira, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2019
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey
Antonin Levy, Lizza E L Hendriks, Cécile Le Péchoux, et al.
Clinical Lung Cancer
|
February 25, 2014
Phase II trial of mapatumumab, a fully human agonist monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
Joachim von Pawel, Jimmie H Harvey, David R Spigel, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 25, 2014
Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer
D F Heigener, K M Deppermann, J V Pawel, et al.
Respiratory Medicine
|
October 13, 2009
Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany
Martin Reck, Rolf A Stahel, Joachim von Pawel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2013
Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin status
Martin J Edelman, Claus-Peter Schneider, Chun-Ming Tsai, et al.
Page
of 152
Search research articles
Search
Showing results (1041-1050 of 1,518) with videos related to
Sort By:
Page
of 152
BMJ Open
|
January 21, 2022
Study protocol of the COMPARE-Interaction study: the impact of maternal comorbid depression and anxiety disorders in the peripartum period on child development
Anna-Lena Zietlow, Christian Franz Josef Woll, Nora Nonnenmacher, et al.
Virchows Archiv : an International Journal of Pathology
|
August 9, 2019
Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients
C Kuempers, L I S van der Linde, M Reischl, et al.
Journal of Thoracic Disease
|
June 11, 2019
Circulating free tumor-derived DNA to detect <i>EGFR</i> mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study
Marc G Denis, Marie-Pierre Lafourcade, Gwenaëlle Le Garff, et al.
Experimental Neurology
|
July 20, 2012
Essential tremor and tremor in Parkinson's disease are associated with distinct 'tremor clusters' in the ventral thalamus
David J Pedrosa, Christiane Reck, Esther Florin, et al.
Journal of Wildlife Diseases
|
January 31, 2024
Molecular Survey of Haemosporidian Parasites in Procellariiformes Sampled in Southern Brazil, 2013-22
Annelise Zabel Sgarioni, Patricia Serafini, Alice Pereira, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2019
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey
Antonin Levy, Lizza E L Hendriks, Cécile Le Péchoux, et al.
Clinical Lung Cancer
|
February 25, 2014
Phase II trial of mapatumumab, a fully human agonist monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
Joachim von Pawel, Jimmie H Harvey, David R Spigel, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 25, 2014
Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer
D F Heigener, K M Deppermann, J V Pawel, et al.
Respiratory Medicine
|
October 13, 2009
Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany
Martin Reck, Rolf A Stahel, Joachim von Pawel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2013
Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin status
Martin J Edelman, Claus-Peter Schneider, Chun-Ming Tsai, et al.
Page
of 152